Q: When the principals at phm caused the sudden downdraft there seemed to be a similar downturn in other pharma stocks in a similar market space. I tend to assume that this will not change until PHM reports earnings on a similar pace as last quarter and/or the market figures out that the new CEO has been highly successful in the past and is likely to be a good one here. 3 specific questions. 1. Do you agree with my above general assessment. 2. Does the new CEO hold an interest in the company/is some compensation in stock? 3) when does phm report earnings
?
Bryon in Elmira.
?
Bryon in Elmira.